Fortis Healthcare moves Supreme Court in Daiichi Sankyo litigation

Fortis Healthcare filed a Special Leave Petition before the Supreme Court on September 16, 2026.
The petition challenges the Delhi High Court judgment dated August 31, 2026, in the Daiichi Sankyo Company, Limited vs. Malvinder Mohan Singh And Ors. matter.

Reader Takeaway: Legal challenge continues, but financial impact remains undisclosed.

What just happened

Fortis Healthcare has approached the Supreme Court against the Delhi High Court order connected with applications filed in the execution proceedings of the long-running dispute.

The petition covers three applications: EX.APPL.(OS) 3764/2022, EX.APPL.(OS) 1615/2025 and EX.APPL.(OS) 3763/2022, all linked to the August 31, 2026 order.

The company had previously disclosed details related to the Delhi High Court order in its announcement dated September 1, 2026.

Why this matters

The case is part of a long-standing legal dispute involving Daiichi Sankyo and former promoters of Fortis Healthcare. The latest filing represents the company’s attempt to seek relief through the apex court against the earlier judgment.

At this stage, Fortis Healthcare has stated that the expected financial implications and quantum of claims are not applicable.

What changes now

The matter will now move through the Supreme Court process, where further hearings and directions will determine the next steps in the litigation.

For shareholders, the key factor remains whether future court proceedings create any financial liability or change the company’s legal position.

What to track next

Investors will watch for Supreme Court proceedings, interim directions and any disclosures from Fortis Healthcare regarding developments in the case.

The current filing is procedural in nature and does not disclose any immediate financial impact on the company.